Moderna and Merck receive FDA breakthrough status for personalized cancer vaccine

In this video

Share

Moderna and Merck receive FDA breakthrough status for personalized cancer vaccine

CNBC's Meg Tirrell reports on news from Moderna and Merck.
03:05
Thu, Feb 23 20237:10 AM EST